Portfolio Investments
Madryn invests in innovative and transformative companies that are driving the future of the healthcare industry
At Madryn, we are much more than a provider of capital. We are business builders and thoughtful strategic partners that possess extensive healthcare industry experience, knowledge and expertise. We take pride in collaborating and working alongside management teams to help them scale their companies, navigate operational challenges, and support their long-term growth.
Aquestive Therapeutics is a pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. The Company has commercialized one internally-developed proprietary product to date, Sympazan, has a commercial proprietary product pipeline focused on the treatment of diseases of the central nervous system, or CNS, and other unmet needs, and is developing orally administered complex molecules to provide alternatives to invasively administered standard of care therapies. The Company also collaborates with other pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven capabilities for drug development and commercialization.